PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID- peg-3350, sodium sulfate, sod United States - English - NLM (National Library of Medicine)

peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid- peg-3350, sodium sulfate, sod

teva pharmaceuticals usa, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is contraindicated in the following conditions: -   gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] -   bowel perforation [see warnings and precautions (5.6)] -   gastric retention -   ileus -   toxic colitis or toxic megacolon -   hypersensitivity to any ingredient in peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution [see warnings and precautions (5.10)] risk summary there are no available data on peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution in pregnant women to inform a drug-associated risk for adverse developmental

SODIUM ASCORBATE AND ASCORBIC ACID PWR STICK Canada - English - Health Canada

sodium ascorbate and ascorbic acid pwr stick

nissan chemical industries ltd. - ascorbic acid (ascorbic acid, sodium ascorbate) - stick - 300mg - ascorbic acid (ascorbic acid, sodium ascorbate) 300mg - vitamin c

Win-Z Plus Syrup (Oral Drops) Philippines - English - FDA (Food And Drug Administration)

win-z plus syrup (oral drops)

solvang pharmaceuticals, inc.; distributor: vamsler phils., inc. - ascorbic acid , zinc - syrup (oral drops) - each ml contains: ascorbic acid (as sodium ascorbate) ascorbic acid (as zinc ascorbate) zinc (as ascorbate) 20.759 mg (equivalent to 23.55 sodium ascorbate) 24.25mg (equivalent to 28.6 zinc ascorbate) . 4.5 mg

OB COMPLETE CHEWABLE- ascorbic acid, sodium ascorbate, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, r United States - English - NLM (National Library of Medicine)

ob complete chewable- ascorbic acid, sodium ascorbate, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, r

vertical pharmaceuticals inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyrid - ascorbic acid 50 mg - ob complete™ chewable is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

MOVIPREP ORANGE powder for oral solution sachet Australia - English - Department of Health (Therapeutic Goods Administration)

moviprep orange powder for oral solution sachet

norgine pty ltd - sodium sulfate, quantity: 7.5 g; macrogol 3350, quantity: 100 g; potassium chloride, quantity: 1.015 g; ascorbic acid, quantity: 4.7 g; sodium ascorbate, quantity: 5.9 g; sodium chloride, quantity: 2.691 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

None Capsule Philippines - English - FDA (Food And Drug Administration)

none capsule

n/a; importer: n/a; distributor: n/a - ascorbic acid (as sodium ascorbate) - capsule - formulation: each 500 mg capsule contains: ascorbic acid (equivalent to 562 mg sodium ascorbate) 500 mg

Sodium Ascorbate Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sodium ascorbate

troy laboratories pty ltd - ascorbic acid as sodium ascorbate - unknown - ascorbic acid as sodium ascorbate vitamin-c active 0.0 - active constituent

None

Dosage 500 mg (equivalent to 562.43 mg Sodium ascorbate)  1,000 IU/10 mg (equivalent to 70 mg Zinc gluconate)

Dosage Philippines - English - FDA (Food And Drug Administration)

none dosage 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

metz pharmaceuticals, inc. - ascorbic acid , cholecalciferol , zinc - capsule classification: over-the-counter (otc) - 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

ASCORBIC ACID injection, solution United States - English - NLM (National Library of Medicine)

ascorbic acid injection, solution

flon laboratories llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

ASCORBIC ACID injection, solution United States - English - NLM (National Library of Medicine)

ascorbic acid injection, solution

raw materials international overseas llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.